Chemed Corporation Financials

Market Capitalization $8.12 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.40
Forward PE	21.76
Price to Sales TTM	$3.41
Price to Book MRQ	$6.54
Enterprise to Revenue	3.36
Enterprise to EBITDA	18.60

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	12.69%
Operating Margin	15.20%
Return on Assets TTM	13.94%
Return on Equity TTM	26.76%

Income Statement

Revenue TTM	$2,377,206,016
Revenue per Share TTM	$157.58
Quarterly Revenue Growth	7.40%
Gross Profit TTM	$847,795,968
EBITDA	$450,981,000
Net Income to Common TTM	$301,732,992
Diluted EPS TTM	$19.77
Quarterly Earnings Growth YoY	1.10%

Balance Sheet

Total Cash MRQ	$238,451,008
Total Cash per Share MRQ	$15.97
Total Debt MRQ	$
Total Debt to Equity MRQ	11.97
Current Ratio MRQ	1.85
Book Value per Share MRQ	$82.78

Cash Flow

Operating Cash Flow TTM	$361,147,008
Levered Free Cash Flow TTM	$228,024,992

CHE Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	14,982,600
Float Shares	14,666,819
Avg 10 Volume	97,560
Avg 30 Volume	None
Shares Short	276,015
Short Ratio	2.66
Short % of Shares	2.13%
% Held by Insiders	2.10%
% Held by Institutions	96.59%

Stock Price Summary

Beta	0.46
Fifty Two Week Low	$512.12
Fifty Two Week High	$654.62
Fifty Two Week Change	-8.34%
Day 50 MA	$546.31
Day 200 MA	$564.09

Dividends and Splits

Forward Annual Dividend Rate	$2.00
Forward Annual Dividend Yield	0.36%
Trailing Annual Dividend Rate	$1.80
Trailing Annual Dividend Yield	0.33%
Payout Ratio	8.59%
Dividend Date	2024-12-06
Ex Dividend Date	2024-11-18
Last Split Factor
Last Split Date	2005-05-12